These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 24473844)

  • 21. Current drug development challenges in chronic kidney disease (CKD)--identification of individualized determinants of renal progression and premature cardiovascular disease (CVD).
    Formentini I; Bobadilla M; Haefliger C; Hartmann G; Loghman-Adham M; Mizrahi J; Pomposiello S; Prunotto M; Meier M
    Nephrol Dial Transplant; 2012 Oct; 27 Suppl 3():iii81-8. PubMed ID: 22734108
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Advancing nursing practice in rhythm recognition with an e-learning educational program.
    Forfa MJ
    Nephrol Nurs J; 2013; 40(2):159-63. PubMed ID: 23767340
    [No Abstract]   [Full Text] [Related]  

  • 23. Cardiovascular complications of chronic kidney disease.
    Ross L; Banerjee D
    Int J Clin Pract; 2013 Jan; 67(1):4-5. PubMed ID: 23241045
    [No Abstract]   [Full Text] [Related]  

  • 24. [Risk factors for cardiovascular system damage in chronic kidney disease].
    Kutyrina IM; Rudenko TE; Savel'eva SA; Shvetsov MIu; Vasil'eva MP
    Ter Arkh; 2013; 85(9):69-76. PubMed ID: 24261233
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chronic kidney disease: the forgotten cardiovascular risk factor.
    Barrios V; Escobar C; Echarri R
    Int J Clin Pract; 2009 Jun; 63(6):964-5. PubMed ID: 19490206
    [No Abstract]   [Full Text] [Related]  

  • 26. Risk prediction in chronic kidney disease: pitfalls and caveats.
    Rigatto C; Sood MM; Tangri N
    Curr Opin Nephrol Hypertens; 2012 Nov; 21(6):612-8. PubMed ID: 23042027
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Kidney disease and cardiovascular risk.
    Tonelli M; Pfeffer MA
    Annu Rev Med; 2007; 58():123-39. PubMed ID: 17081079
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypertension and cardiovascular risk in chronic kidney disease.
    Luño J; Iturbe BR; Zoccali C
    Nephrol Dial Transplant; 2012 Dec; 27 Suppl 4():iv1. PubMed ID: 23258803
    [No Abstract]   [Full Text] [Related]  

  • 29. Management of anaemia in chronic kidney disease: summary of updated NICE guidance.
    Padhi S; Glen J; Pordes BA; Thomas ME;
    BMJ; 2015 Jun; 350():h2258. PubMed ID: 26044132
    [No Abstract]   [Full Text] [Related]  

  • 30. Preclinical cardiovascular abnormalities in patients in early stages of renal disease without nephrotic syndrome.
    Esposito P; Palmieri V; Migliaresi P; Pezzullo S; Martino S; Balletta MM
    Hypertens Res; 2009 Dec; 32(12):1155-6. PubMed ID: 19851328
    [No Abstract]   [Full Text] [Related]  

  • 31. [Diabetes mellitus related common medical disorders recent progress in diagnosis and treatment. Topics: I. Pathophysiology, diagnosis and treatment; 7. Chronic kidney disease. ].
    Haneda M
    Nihon Naika Gakkai Zasshi; 2013 Apr; 102(4):875-81. PubMed ID: 23772501
    [No Abstract]   [Full Text] [Related]  

  • 32. It's about time: extending our understanding of cardiovascular risk from chronic kidney disease.
    Young A; Garg AX
    J Am Soc Nephrol; 2009 Dec; 20(12):2486-7. PubMed ID: 19892933
    [No Abstract]   [Full Text] [Related]  

  • 33. Comparison of the MDRD Study and the CKD-EPI Study equations in evaluating trends of estimated kidney function at population level: findings from the National FINRISK Study.
    Juutilainen A; Kastarinen H; Antikainen R; Peltonen M; Salomaa V; Tuomilehto J; Jousilahti P; Sundvall J; Laatikainen T; Kastarinen M
    Nephrol Dial Transplant; 2012 Aug; 27(8):3210-7. PubMed ID: 22492828
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Epidemiology of chronic kidney disease].
    Noël D; Landais P
    Rev Prat; 2012 Jan; 62(1):38-42. PubMed ID: 22335065
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapy for the altered mineral metabolism of chronic kidney disease: implications for vascular calcification.
    Saab G; Whaley-Connell AT; Khanna R; Sowers JR
    Ther Adv Cardiovasc Dis; 2007 Dec; 1(2):107-12. PubMed ID: 19124399
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of Renal Function and Renal Risk in the Twenty-First Century.
    Porrini E; Warnock DG
    Nephron; 2017; 136(4):261-262. PubMed ID: 28478448
    [No Abstract]   [Full Text] [Related]  

  • 37. Emerging role of post-translational modifications in chronic kidney disease and cardiovascular disease.
    Gajjala PR; Fliser D; Speer T; Jankowski V; Jankowski J
    Nephrol Dial Transplant; 2015 Nov; 30(11):1814-24. PubMed ID: 25862763
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chronic kidney disease and cardiovascular disease.
    Bondugulapati LN; Shandilya S
    Curr Opin Lipidol; 2015 Aug; 26(4):353-4. PubMed ID: 26164730
    [No Abstract]   [Full Text] [Related]  

  • 39. [Development of evaluation of kidney function and classification of chronic kidney disease (CKD)--including CKD clinical practice guide 2012].
    Horio M
    Rinsho Byori; 2013 Jul; 61(7):616-21. PubMed ID: 24205704
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypertension and chronic kidney disease.
    Gargiulo R; Suhail F; Lerma EV
    Dis Mon; 2015 Sep; 61(9):387-95. PubMed ID: 26328515
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.